Completed OBSERVATIONAL NCT04548024

Relation of Non-invasively Measured Parameters to Clinical Outcomes in CHF Patients

Relation of Non-invasively Measured Advanced Hemodynamic Parameters to Clinical Outcomes in Heart Failure Patients

Sponsor: Biobeat Technologies Ltd.

Updated 6 times since 2020 Last updated: Dec 9, 2021 Started: Sep 10, 2020 Primary completion: Nov 10, 2021 Completion: Dec 10, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Congestive Heart Failure and is currently completed. Biobeat Technologies Ltd. leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Jan 2021 — Jan 2022 [monthly]

Recruiting
Dec 2020 — Jan 2021 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Oct 2020 — Dec 2020 [monthly]

Not Yet Recruiting

First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biobeat Technologies Ltd.

Data source: Biobeat Technologies Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jerusalem, Israel